ABOUT ALMAC CLINICAL TECHNOLOGIES
Almac Clinical Technologies is a trusted partner providing industry-leading clinical trial technology, expertise, and seamless service at every stage of the participant journey. Supporting biopharmaceutical sponsors and CROs in accelerating drug development through its industry-leading Interactive Response Technology (IRT) and integrated electronic Clinical Outcome Assessment (eCOA) platform.
With a steadfast commitment to quality, Almac embeds compliance, precision, and reliability into every phase of the clinical trial process. Its solutions streamline site, patient, and supply management while delivering real-time data and intuitive tools that enable informed, data-driven decisions and enhance global participant engagement.
FEATURED ARTICLES
-
![GettyImages-525755915 clinical team eCOA]( "The Strategic Advantage Of eCOA And IRT")
The future lies in unified, interoperable eCOA–IRT solutions that streamline operations, improve data integrity, and enhance patient and site experience.
-
![laboratory scientist laptop GettyImages-1302454417]( "Future Predictions For Clinical Technologies: A Smarter, More Connected Era")
In 2025, sponsors are prioritizing configurable, interoperable solutions that integrate seamlessly across IRT, eCOA, CTMS, eConsent, and supply chain systems.
CONTACT INFORMATION
Almac Clinical Technologies
20 Seagoe Industrial Estate
Craigavon, BT63 5QD
UNITED KINGDOM
FEATURED SOLUTIONS
-
![GettyImages-2183708450-doctor-with-patient-tablet-doctors-office]( "eCOA: Participant-Focused Electronic Assessment Capture Built For Global Trials")
High-quality outcome data is essential to clinical trial success, and this eCOA solution provides participant-first design features while supporting multiple modalities.
